Pennsylvania Republican Party Registers over 243,000 New

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone john1234 #9822
Pennsylvania Republican Party Registers over 243,000 New Voters, Including Nearly 100,000 Former Democrats

Almost 100,ooo Pennsylvania Democrats switched their party affiliation to Republican in the past ten months.


CBS Pittsburgh reports that 97,607 Pennsylvania voters made the switch from Democrat to Republican since the beginning of 2016, whereas 38,020 Republicans changed their party affiliation to Democrat.

“The surge in Republican registrations is nearly twice the number of newly registered Republicans compared to both the 2008 and 2012 numbers combined,” the Pennsylvania GOP said in a statement, calling their gains “historic.”

Since November 2015, the Pennsylvania GOP registered 243,139 new Republican voters.

The Atlantic magazine published a detailed examination of lifelong Pennsylvania Democrats staunchly supporting Trump:

Paul Sracic, a Youngstown State University political scientist, believes there are two categories of voters rallying to support Trump. “First, there are people who don’t normally vote,” he said. “Nearly half the voting-age population was either not registered to vote, or was registered and decided not to vote in 2012. And if even 10 percent of that group was to show up and vote this year, it could easily change the outcome in the important swing states.”

Sracic—who frankly admits he obsesses over opinion polls—wonders whether these voters are even represented in the endless presidential surveys: “If people aren’t registered voters, they won’t be picked up by most polls. If they are registered voters but don’t normally vote, they may be eliminated by ‘likely voter’ screens pollsters use.” Romney lost Pennsylvania in 2012 by about 300,000 votes out of about 5.5 million cast; in Ohio, he lost by less than 200,000. “So bringing new people in can make a difference,” Sracic said.

Potentially more significant, however, are those voters who “flip”—Sracic’s second category. “Remember,” he said, “taking a Democratic voter and having them vote Republican is both a +1 and a -1. In other words, if Romney lost Pennsylvania by 300,000 voters, all you have to do [this time] is flip slightly more than 150,000 votes.” Between Ohio and Pennsylvania, if approximately 225,000 voters (out of the 11 million who are expected on Election Day) switch parties, they could tip the entire election.

“Writers such as National Review’s correspondent Kevin Williamson have suggested that people who live in communities that are experiencing economic hard times should just pack up and move somewhere else,” said Sracic.

He believes that Williamson and others like him actually have a very narrow understanding of what constitutes and promotes happiness and wellbeing: “People need jobs and enough money to survive, but they also desire community. Friends and family are important. When we talk about ‘creative destruction’ as being part of a vibrant national economy, we sometime miss the real damage that is done to the networks that sustain us.”

If nearly everyone moves away, who is going to take care of mom and dad as they age? Are they expected to pull up roots, too, and leave the people and places they have known their whole lives? Many do leave, of course. Others stay—and watch the economy collapse around them. To many of these voters, Trump offers the hope that they won’t have to make such an awful choice.

One coal industry worker who registered to vote for the first time in 61 years told the Atlantic: “This is about me. I am doing this for me, my hometown.”

Clinton holds a small lead over Trump in recent Pennsylvania polls.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 1

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading

Top 5 Most Recently Viewed Articles

Prologis Earnings Report: Investors' Key Insights and Analysis

Updated Category News Views 138

Understanding Prologis's Upcoming Quarterly Earnings Prologis (NYSE: PLD) is set to release its latest quarterly earnings report, and investors are eagerly awaiting the insights it will provide. As the company approaches its earnings announcement, analysts project an earnings per share (EPS) of $1.02, which serves as a benchmark for performance expectations. Investor...

Continue Reading
How Changing U.S. Jobs Report Affects Market Dynamics

Updated Category News Views 171

The recent U. S. employment report sent shockwaves through financial markets, reshaping how traders and investors eyed their portfolios. Stronger-than-expected job creation—with figures soaring over 100,000—meant one thing: the narrative on interest rates was about to change. Gone were the days of comfortably betting on rate cuts; now, everyone’s scrambling to...

Continue Reading
Suno Boosts Innovation for Creators by Acquiring WavTool

Updated Category News Views 157

Suno Boosts Innovation for Creators by Acquiring WavTool Suno has recently made a significant move in the music industry with their acquisition of WavTool. This strategic decision aims to enhance their offerings for songwriters and producers, enabling them to create music that resonates with a broader audience. By integrating WavTool's advanced capabilities into their...

Continue Reading
Leqembi's New IV Treatment Approval: A Milestone for Alzheimer’s Care

Updated Category News Views 274

Leqembi Approved for IV Maintenance Treatment BioArctic AB, a notable player in the biopharmaceutical sector, has made significant headlines with the approval of Leqembi (lecanemab) for intravenous (IV) maintenance treatment for Alzheimer’s disease in the United Kingdom. This groundbreaking decision was announced following rigorous evaluations by the Medicines and...

Continue Reading
Investors of ATYR, MLTX, BAX, and JHX Have Legal Options

Updated Category News Views 145

Overview of Class Action Lawsuits for ATYR, MLTX, BAX, JHX Attention investors! If you’ve invested in aTyr Pharma Inc. (NASDAQ: ATYR), MoonLake Immunotherapeutics (NASDAQ: MLTX), Baxter International, Inc. (NYSE: BAX), or James Hardie Industries plc (NYSE: JHX), it’s important to be aware of significant class action lawsuits affecting your investments. These companies...

Continue Reading